Cardiovascular disease remains the leading cause of death worldwide, with heightened risks observed in patients managing diabetes and prediabetes. Clinicians have long recommended high fiber intake to improve metabolic health; however, recent evidence suggests that the relationship between dietary fibre and CVD risk is not uniform. Specifically, the baseline glycemic status of a patient significantly dictates how much cardiovascular protection they derive from dietary fiber.

Optimizing Dietary Fibre and CVD Risk through Microbiota

A comprehensive analysis of 207,413 participants across four multiethnic cohorts has shed new light on this interaction. For individuals with normal blood sugar or prediabetes, each standard deviation increase in fiber intake reduced cardiovascular mortality by 11%. Furthermore, these participants experienced a 6% to 12% reduction in major adverse cardiovascular events (MACE). In contrast, researchers found no significant reduction in MACE risk among individuals already diagnosed with diabetes. This discrepancy suggests that metabolic dysfunction might blunt the typical cardiovascular benefits of fiber consumption.

Moreover, the study explored the gut microbiome as a potential mediator of these outcomes. They developed an exploratory microbiota index that tracks beneficial genera, such as Lachnospiraceae, and pro-inflammatory genera, like Desulfovibrio. This index demonstrated a more universal benefit; it was inversely associated with MACE risk regardless of diabetes status, yielding a 17% to 23% risk reduction. Consequently, while fiber intake alone may show varying efficacy, the underlying health of the gut microbiota remains a powerful predictor of heart health.

Ultimately, these findings highlight the necessity of personalized nutrition in clinical practice. The correlation between energy-adjusted fiber intake and the beneficial microbiota index was only significant in non-diabetic individuals. Therefore, patients with diabetes may require targeted interventions to modulate their microbiome, as traditional fiber increases may not suffice. Identifying specific microbial markers can help physicians tailor dietary strategies to those who will benefit most from dietary fibre and CVD risk reduction interventions.

Frequently Asked Questions

Does dietary fiber help diabetic patients reduce heart disease risk?

While fiber intake is essential for general health, this study suggests that its direct association with reduced major adverse cardiovascular events (MACE) is weaker in those with established diabetes compared to those with normoglycemia or prediabetes.

Which gut bacteria are linked to lower cardiovascular risk?

Beneficial genera like Lachnospiraceae are associated with lower cardiovascular risk, while pro-inflammatory bacteria like Desulfovibrio are linked to higher risk. A healthy balance of these microbes helps protect the heart across all glycemic levels.

Should doctors focus on fiber or gut health markers?

Both are important, but for diabetic patients, gut microbiota markers may provide a more accurate assessment of cardiovascular risk and potential response to dietary changes than fiber intake alone.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

1. Li Y et al. Dietary Fibre, Gut Microbiota and Cardiovascular Outcomes: Differential Associations by Diabetes Status in Multiethnic Cohorts. Diabetes Obes Metab. 2026 Apr 13. doi: 10.1111/dom.70754. PMID: 41969199.


2. Reynolds A, et al. Carbohydrate quality and human health: a series of systematic reviews and meta-analyses. Lancet. 2019 Feb 2;393(10170):434-445.


3. Toya T, et al. Coronary artery disease is associated with an altered gut microbiome composition. PLoS ONE. 2020;15(1):e0227147.